<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Drug and Medication Industry: Market Research Reports, Statistics and Analysis]]></title>
    <link>http://www.reportlinker.com/ci02260/Drug-and-Medication.html</link>
    <description><![CDATA[Reportlinker.com Lastest Drug and Medication Industry: Market Research Reports, Statistics and Analysis]]></description>
    <pubDate>Thu, 23 May 2013 05:29:00 +0000</pubDate>
    <webMaster>helpdesk@reportlinker.com</webMaster>
    <copyright>Copyright 2013, Reportlinker</copyright>
    <generator>Zend_Feed</generator>
    <language>en-us</language>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Company Report: Drug for Year 2013]]></title>
      <link>http://www.reportlinker.com/d014229709/Company-Report-Drug-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014229709/Company-Report-Drug-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[U.S. Drug and Medication Business Analysis]]></title>
      <link>http://www.reportlinker.com/d014353968/U-S-Drug-and-Medication-Business-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014353968/U-S-Drug-and-Medication-Business-Analysis.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug and Medication Sector in The United States]]></title>
      <link>http://www.reportlinker.com/d014353761/Drug-and-Medication-Sector-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014353761/Drug-and-Medication-Sector-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Of emerging  contaminants in water supplies   <Strong>antidepressants</strong>, endocrine disruptors   Impacts on aquatic life   Strengthening of the regulatory framework   Baseline of data for drinking water supplies   Assess ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Sector in Africa]]></title>
      <link>http://www.reportlinker.com/d014279677/Drug-Sector-in-Africa.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014279677/Drug-Sector-in-Africa.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... Equity of  access on paper but  weak 1010  20/04/2013 harm reduction as a policy pillar is:    Rejected by nigeria;   Included in 2012-16 <strong>drug</strong> master plan of so africa  but defined as achieved through treatment ...]]></description>
      <pubDate>Sun, 31 Mar 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Medicine Sector in Malaysia]]></title>
      <link>http://www.reportlinker.com/d014352188/Medicine-Sector-in-Malaysia.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014352188/Medicine-Sector-in-Malaysia.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Of generic medicines    Reliable & sustainable  national financing  mechanism    To ensure the poor and  underprivileged are not  denied access to  essential medicines         generic policies price of <strong>drugs</strong> ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Industry Analysis  in The United States and Canada]]></title>
      <link>http://www.reportlinker.com/d014323762/Drug-Industry-Analysis-in-The-United-States-and-Canada.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014323762/Drug-Industry-Analysis-in-The-United-States-and-Canada.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_ppt_small.gif" width="65px" height="80px"> ... To production interruptions and  diminished capacity    Economic choices are made where older,  less profitable <strong>drugs</strong> are eliminated as new  generics come to market   By year-end 2012, we will see $34b in new ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug and Medication Sector in Malaysia]]></title>
      <link>http://www.reportlinker.com/d014321956/Drug-and-Medication-Sector-in-Malaysia.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014321956/Drug-and-Medication-Sector-in-Malaysia.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Adulterants were found to be therapeutic substances  associated with the specific indications of the products such as  adulterant for sexual enhancement <strong>drugs</strong> ( sildenafil, tadalafil ), pain  relieving <strong>drugs</strong> ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vaccine Market in Tanzania]]></title>
      <link>http://www.reportlinker.com/d014338643/Vaccine-Market-in-Tanzania.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014338643/Vaccine-Market-in-Tanzania.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Of a <strong>polio</strong> <strong>vaccine</strong> what does it take to vaccinate a child against polio  This two-minute video from unicef shows us that  the journey of a <strong>polio</strong> <strong>vaccine</strong> is an incredibly complex process. The menafrivac ctc ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Drug Sector in Nigeria]]></title>
      <link>http://www.reportlinker.com/d014350042/Drug-Sector-in-Nigeria.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014350042/Drug-Sector-in-Nigeria.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[The European Medicine Market : Innovation and Technology Trends]]></title>
      <link>http://www.reportlinker.com/d014351443/The-European-Medicine-Market-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</link>
      <guid>http://www.reportlinker.com/d014351443/The-European-Medicine-Market-Innovation-and-Technology-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public</guid>
      <description><![CDATA[<img src="http://img.reportlinker.com/public/images/defaut_pdf_small.gif" width="65px" height="80px"> ... Government organised a public tender for the  <strong>hpv</strong> <strong>vaccines</strong>. This tender led to price reductions from  375 To  52.                                                                53  Stroetmann k. A., Jones t ...]]></description>
      <pubDate>Tue, 30 Apr 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vaccines - Global Markets Package]]></title>
      <link>http://www.reportlinker.com/p01181924/Vaccines-Global-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01181924/Vaccines-Global-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different countries around the world. The studies provide essential market ...]]></description>
      <pubDate>Sun, 19 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vaccines - European Markets Package]]></title>
      <link>http://www.reportlinker.com/p01181922/Vaccines-Western-European-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01181922/Vaccines-Western-European-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different European countries. The studies provide essential market information ...]]></description>
      <pubDate>Sun, 19 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vaccines - Asian Markets Package]]></title>
      <link>http://www.reportlinker.com/p01181920/Vaccines-Asian-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01181920/Vaccines-Asian-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Asian countries. The studies provide essential market information ...]]></description>
      <pubDate>Sun, 19 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Vaccines - Eastern European Markets Package]]></title>
      <link>http://www.reportlinker.com/p01181921/Vaccines-Eastern-European-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01181921/Vaccines-Eastern-European-Markets-Package.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1469.gif"> This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Eastern European countries. The studies provide essential market ...]]></description>
      <pubDate>Sun, 19 May 2013 22:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[PharmaPoint: Osteoporosis - Germany Drug Forecast and Market Analysis to 2022]]></title>
      <link>http://www.reportlinker.com/p01158413/PharmaPoint-Osteoporosis-Germany-Drug-Forecast-and-Market-Analysis-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01158413/PharmaPoint-Osteoporosis-Germany-Drug-Forecast-and-Market-Analysis-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> PharmaPoint: Osteoporosis - Germany Drug Forecast and Market Analysis to 2022  Summary  GlobalData has released its new Country report, ?PharmaPoint: Osteoporosis - Germany Drug Forecast and Market Analysis ...]]></description>
      <pubDate>Wed, 27 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022]]></title>
      <link>http://www.reportlinker.com/p01158412/PharmaPoint-Osteoporosis-France-Drug-Forecast-and-Market-Analysis-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01158412/PharmaPoint-Osteoporosis-France-Drug-Forecast-and-Market-Analysis-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis to 2022  Summary  GlobalData has released its new Country report, ?PharmaPoint: Osteoporosis - France Drug Forecast and Market Analysis ...]]></description>
      <pubDate>Wed, 27 Feb 2013 23:00:00 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022]]></title>
      <link>http://www.reportlinker.com/p01190416/PharmaPoint-Pediatric-Respiratory-Syncytial-Virus-RSV-Prophylactics-US-Drug-Forecast-and-Market-Analysis-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</link>
      <guid>http://www.reportlinker.com/p01190416/PharmaPoint-Pediatric-Respiratory-Syncytial-Virus-RSV-Prophylactics-US-Drug-Forecast-and-Market-Analysis-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium</guid>
      <description><![CDATA[<img src="https://d99ngkg9mjpdb.cloudfront.net/public/images/pub/1357.gif"> PharmaPoint: Pediatric Respiratory Syncytial Virus (RSV) Prophylactics - US Drug Forecast and Market Analysis to 2022  Summary  Respiratory syncytial virus (RSV) is a common cause of pediatric respiratory ...]]></description>
      <pubDate>Mon, 29 Apr 2013 22:00:00 +0000</pubDate>
    </item>
  </channel>
</rss>
